A Two-Week, Randomised, Double-Blind Study Assessing the Onset of Effect Questionnaire Administered Daily Versus Weekly in Adult Subjects (greater than or equal to 18 Years) With Mild to Moderate Asthma, Receiving SYMBICORT pMDI 80/4.5 μg x 2 Actuations Twice Daily or Budesonide HFA pMDI 80 μg x 2 Actuations Twice Daily

Trial Profile

A Two-Week, Randomised, Double-Blind Study Assessing the Onset of Effect Questionnaire Administered Daily Versus Weekly in Adult Subjects (greater than or equal to 18 Years) With Mild to Moderate Asthma, Receiving SYMBICORT pMDI 80/4.5 μg x 2 Actuations Twice Daily or Budesonide HFA pMDI 80 μg x 2 Actuations Twice Daily

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Dec 2009

At a glance

  • Drugs Budesonide; Budesonide/formoterol
  • Indications Asthma
  • Focus Therapeutic Use
  • Sponsors AstraZeneca
  • Most Recent Events

    • 11 Jan 2008 Status changed from in progress to completed.
    • 12 Oct 2007 Status changed from recuiting to in progress.
    • 28 May 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top